4//SEC Filing
Laliberte Kevin 4
Accession 0001209191-18-019559
CIK 0001685071other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:24 PM ET
Size
5.5 KB
Accession
0001209191-18-019559
Insider Transaction Report
Form 4
Laliberte Kevin
Sr. VP, Product Development
Transactions
- Award
Stock Option (right to buy)
2018-03-12+50,000→ 50,000 totalExercise: $29.33Exp: 2028-03-11→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]One-fourth of the shares underlying this option vest on March 12, 2019 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.
Documents
Issuer
Dova Pharmaceuticals, Inc.
CIK 0001685071
Entity typeother
Related Parties
1- filerCIK 0001709417
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 4:24 PM ET
- Size
- 5.5 KB